S&P Global downgrades BellRing Brands rating on weak margins By Investing.com

S&P Global Ratings downgraded BellRing Brands to 'B+' from 'BB-' and revised the outlook to negative, citing weaker Premier Protein trends, elevated costs, and a forecast >30% decline in adjusted EBITDA in fiscal 2026. S&P now expects adjusted leverage to rise to 3.7x from 2.4x, EBITDA margin to compress to 14% from 21%, and free operating cash flow to fall to about $30 million from $254 million. The company also faces a $90 million legal settlement payment and competitive pressure in the club channel, where Premier Protein consumption fell 7.3% in Q2.

Analysis

The downgrade is less about one bad quarter and more about a regime change in the category: protein RTD is moving from scarcity pricing to shelf-space warfare. In that setup, the weakest balance sheets are the first to lose promotional flexibility, which matters because this is a high-fixed-cost, working-capital-heavy model where small changes in mix and promo intensity can overwhelm volume growth. The second-order loser is the broader “growth at any price” packaged-food cohort, since distributors and club retailers will likely demand more funding support across adjacent protein/snack categories, compressing margins even for names not directly named here.

The near-term catalyst path is unfavorable over the next 1-2 quarters because cash is tightening exactly when management would normally defend share. Buybacks funded alongside revolver utilization are a red flag: they convert an earnings problem into a capital-structure problem, and ratings pressure can become self-reinforcing if vendor terms shorten or shelf confidence weakens. If leverage drifts above 4x, the market will likely stop treating this as a temporary margin reset and start pricing in either an equity raise or more aggressive asset/risk management.

The more interesting read-through is to Coca-Cola. The issue is not KO beta; it is whether Fairlife can sustain premium elasticity while the category becomes more promotional. If incumbents respond with heavier trade spend, KO may keep volume but give back mix, so the “winner” can still underperform on margin. In contrast, private-label and insurgent brands may gain the most incremental unit share if consumers stay trade-down oriented, while suppliers of protein inputs and club-channel retailers could see higher volumes but more volatile margins.

Key Decisions for Investors

• Short BRBR for 1-3 months into any relief rally; the setup favors continued downside as cash flow and leverage metrics worsen before any fundamental reset. Use a defined-risk structure if preferred: buy 1-2 quarter put spreads rather than outright short to avoid squeeze risk.
• Pair trade: long KO / short BRBR for 2-4 months. The thesis is that premium protein demand remains intact at the category level, but BRBR’s margin structure is far more fragile; KO should better absorb promotional pressure through scale and mix.
• Consider a basket short of vulnerable branded-consumer names with high promo dependence and weak balance sheets versus staples quality longs. The objective is to isolate the valuation reset from a broader market move in defensives.
• Do not add to BRBR until there is evidence of channel stabilization and leverage turning lower; the earliest credible inflection is likely not before the next 1-2 reporting cycles. Any improvement before then is more likely inventory noise than durable demand recovery.
• For event-driven traders, watch for covenant language, vendor financing changes, or incremental guidance cuts as higher-conviction catalysts than the rating action itself; those would justify pressing the short with a tighter stop.